+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Muscle Relaxants Drug Market by Product Type, Distribution Channel, End User, Route of Administration, Drug Form - Global Forecast to 2030- Product Image
Muscle Relaxants Drug Market by Product Type, Distribution Channel, End User, Route of Administration, Drug Form - Global Forecast to 2030- Product Image
Sale

Muscle Relaxants Drug Market by Product Type, Distribution Channel, End User, Route of Administration, Drug Form - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968778
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The muscle relaxants drug market is advancing as stakeholders respond to evolving clinical needs, regulatory shifts, and supply chain challenges. Optimized therapies, digital integration, and adaptive manufacturing are shaping strategy and growth, with businesses seeking robust insights for confident decision-making.

Market Snapshot: Muscle Relaxants Drug Market

The Muscle Relaxants Drug Market grew from USD 4.78 billion in 2024 to USD 5.18 billion in 2025. The market is projected to continue expanding at a CAGR of 7.91%, reaching USD 7.56 billion by 2030. Strong drivers include advancements in pharmacology, broadening applications across chronic and acute muscle conditions, and a greater focus on safety and tailored outcomes. Industry players face decisions against a backdrop of new U.S. tariffs and shifting reimbursement standards.

Scope & Segmentation

  • Product Types: Neuromuscular blockers (depolarizing and non-depolarizing) and spasmolytics (centrally acting and direct acting) address distinct therapeutic requirements from acute surgical intervention to chronic spasm control.
  • Distribution Channels: Hospital pharmacies, retail pharmacies, online outlets via manufacturer sites, and third-party e-retailers support reach across inpatient, outpatient, and direct-to-patient settings.
  • End Users: Ambulatory surgical centers, hospitals, and specialty clinics drive adoption based on procedural complexity and patient profile.
  • Route of Administration: Both injectable and oral options serve immediate clinical demands and routine outpatient care.
  • Drug Forms: Capsules, tablets, liquid preparations, and injectable solutions enable precision dosing and accessibility for all age groups.
  • Regions Covered: Americas (including United States, Canada, Brazil, Mexico, Argentina), Europe, Middle East & Africa (including UK, Germany, France, Russia, IL, Spain, UAE, Saudi Arabia, South Africa, and others), Asia-Pacific (including China, India, Japan, Australia, South Korea, and key Southeast Asian markets).
  • Industry Participants: Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Viatris Inc., Acorda Therapeutics, Novartis AG, Endo International plc, Bausch Health Companies, Pfizer Inc., Amneal Pharmaceuticals, Upsher-Smith Laboratories, and more.
  • Technological Innovations: Digital health platforms, connected wearable devices, and data-driven precision medicine approaches, alongside advanced continuous manufacturing methods, are redefining therapeutic development and patient engagement.

Key Takeaways for Decision-Makers

  • Regulatory agencies are strengthening efficacy and safety guidelines, requiring manufacturers to update formulations and delivery systems.
  • Investment in patient-centric care, including remote monitoring and digital adherence solutions, is increasingly vital for therapy differentiation and market access.
  • Process innovation in manufacturing, such as continuous production and predictive analytics, is enhancing scalability and supply stability for muscle relaxant drugs.
  • Competitive edges are being established through clinical validation, regional collaborations, and entry into under-served therapeutic segments like pediatric and rare disorders.
  • Channel diversification, including omnichannel pharmacy strategies, is crucial as outpatient and direct-to-patient trends strengthen post-pandemic.

Tariff Impact: Navigating New US Trade Policies

The 2025 US tariff framework has led to higher costs for importing key raw materials and active ingredients, pushing manufacturers to re-examine sourcing and pricing structures. Some companies now favor domestic and nearshore suppliers, while others invest in local production and strategic inventory management. Distributors are renegotiating contracts to absorb increased logistics and customs costs, requiring new frameworks for payers and healthcare providers around reimbursement and value-based contracting. Long-term, success depends on supply chain diversification and transparent pricing strategies.

Methodology & Data Sources

This analysis utilized in-depth interviews with clinical and market experts across therapeutic, regulatory, and procurement arenas, complemented by secondary reviews of peer-reviewed journals, regulatory filings, patent data, and market analytics. Data triangulation, rigorous validation, and cross-referencing with proprietary and public sources ensured accuracy and depth of insights.

Why This Report Matters

  • Provides senior leaders with actionable intelligence to align R&D, commercial, and supply strategies for sustained growth amid shifting regulatory and cost environments.
  • Clarifies region-specific opportunities and risks, supporting investment and partnership decisions in muscle relaxants across global and emerging markets.

Conclusion

The muscle relaxants drug market rewards agility, cross-sector collaboration, and data-backed decision-making. Stakeholders applying these insights will be positioned to navigate change and capitalize on strategic opportunities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Muscle Relaxants Drug Market, by Product Type
8.1. Introduction
8.2. Neuromuscular Blocker
8.2.1. Depolarizing
8.2.2. Non Depolarizing
8.3. Spasmolytic
8.3.1. Centrally Acting
8.3.2. Direct Acting
9. Muscle Relaxants Drug Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.3.1. Manufacturer Websites
9.3.2. Third Party E Retailers
9.4. Retail Pharmacies
10. Muscle Relaxants Drug Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Muscle Relaxants Drug Market, by Route of Administration
11.1. Introduction
11.2. Injectable
11.3. Oral
12. Muscle Relaxants Drug Market, by Drug Form
12.1. Introduction
12.2. Capsule
12.3. Injectable Solution
12.4. Liquid
12.5. Tablet
13. Americas Muscle Relaxants Drug Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Muscle Relaxants Drug Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Muscle Relaxants Drug Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Ltd.
16.3.2. Sandoz International GmbH
16.3.3. Viatris Inc.
16.3.4. Acorda Therapeutics, Inc.
16.3.5. Endo International plc
16.3.6. Novartis AG
16.3.7. Bausch Health Companies Inc.
16.3.8. Pfizer Inc.
16.3.9. Amneal Pharmaceuticals LLC
16.3.10. Upsher-Smith Laboratories, LLC
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. MUSCLE RELAXANTS DRUG MARKET MULTI-CURRENCY
FIGURE 2. MUSCLE RELAXANTS DRUG MARKET MULTI-LANGUAGE
FIGURE 3. MUSCLE RELAXANTS DRUG MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. MUSCLE RELAXANTS DRUG MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. MUSCLE RELAXANTS DRUG MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MUSCLE RELAXANTS DRUG MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DEPOLARIZING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY NON DEPOLARIZING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY CENTRALLY ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DIRECT ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY THIRD PARTY E RETAILERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. CANADA MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 54. CANADA MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 55. CANADA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. CANADA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 57. CANADA MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. CANADA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 59. CANADA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 60. MEXICO MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. MEXICO MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 62. MEXICO MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 63. MEXICO MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. MEXICO MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 65. MEXICO MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. MEXICO MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 67. MEXICO MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 101. GERMANY MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. GERMANY MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 103. GERMANY MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 104. GERMANY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. GERMANY MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 106. GERMANY MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. GERMANY MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 108. GERMANY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 109. FRANCE MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. FRANCE MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 111. FRANCE MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 112. FRANCE MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. FRANCE MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 114. FRANCE MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. FRANCE MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 116. FRANCE MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 125. ITALY MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. ITALY MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 127. ITALY MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 128. ITALY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. ITALY MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 130. ITALY MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. ITALY MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 132. ITALY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 133. SPAIN MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. SPAIN MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 135. SPAIN MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 136. SPAIN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. SPAIN MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 138. SPAIN MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. SPAIN MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 140. SPAIN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 149. SAUDI ARABIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. SAUDI ARABIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 157. SOUTH AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 165. DENMARK MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. DENMARK MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 167. DENMARK MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 168. DENMARK MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. DENMARK MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 170. DENMARK MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. DENMARK MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 172. DENMARK MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 181. QATAR MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. QATAR MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 183. QATAR MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 184. QATAR MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. QATAR MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 186. QATAR MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. QATAR MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 189. FINLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. FINLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 191. FINLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 192. FINLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. FINLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 194. FINLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. FINLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. FINLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 197. SWEDEN MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. SWEDEN MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 213. EGYPT MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. EGYPT MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 215. EGYPT MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 216. EGYPT MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. EGYPT MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 218. EGYPT MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. EGYPT MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 220. EGYPT MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 221. TURKEY MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 223. TURKEY MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 224. TURKEY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. TURKEY MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 226. TURKEY MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. TURKEY MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. TURKEY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 237. NORWAY MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. NORWAY MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 239. NORWAY MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 240. NORWAY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. NORWAY MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 242. NORWAY MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. NORWAY MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 244. NORWAY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 245. POLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. POLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 247. POLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 248. POLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. POLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 250. POLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. POLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 252. POLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 270. CHINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. CHINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 272. CHINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 273. CHINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. CHINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 275. CHINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. CHINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 277. CHINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 278. INDIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. INDIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 280. INDIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 281. INDIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. INDIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 283. INDIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. INDIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 285. INDIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 286. JAPAN MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. JAPAN MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 288. JAPAN MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 289. JAPAN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. JAPAN MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 291. JAPAN MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. JAPAN MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 293. JAPAN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 310. INDONESIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 311. INDONESIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 318. THAILAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 319. THAILAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 320. THAILAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 321. THAILAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. THAILAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 323. THAILAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 324. THAILAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 325. THAILAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG FORM, 2018-2030 (USD MILLION)
TABLE 326. PHILIPPINES MUSCLE RELAXANTS DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 327. PHILIPPINES MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR BLOCKER, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES MUSCLE RELAXANTS DRUG MARKET SIZE, BY SPASMOLYTIC, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES MUSCLE RELAXANTS DRU

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Muscle Relaxants Drug market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Viatris Inc.
  • Acorda Therapeutics, Inc.
  • Endo International plc
  • Novartis AG
  • Bausch Health Companies Inc.
  • Pfizer Inc.
  • Amneal Pharmaceuticals LLC
  • Upsher-Smith Laboratories, LLC

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.18 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.56 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Muscle Relaxant Drugs - Global Strategic Business Report - Product Image

Muscle Relaxant Drugs - Global Strategic Business Report

  • Report
  • 371 Pages
  • Global
From
Muscle Relaxant Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Muscle Relaxant Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Muscle Relaxant Drugs Market Report 2025 - Product Image

Muscle Relaxant Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Muscle Relaxant Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Muscle Relaxant Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 86 Pages
  • Global
From
Krabbe Disease Treatment - Global Strategic Business Report - Product Image

Krabbe Disease Treatment - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From

About the Muscle Relaxant Market

The Muscle Relaxant market is a subset of the Central Nervous System Drugs market. Muscle relaxants are drugs that are used to reduce muscle spasms, tension, and stiffness. They are commonly used to treat conditions such as muscle spasms, neck and back pain, fibromyalgia, and multiple sclerosis. Muscle relaxants can be divided into two categories: non-depolarizing and depolarizing. Non-depolarizing muscle relaxants are used to reduce muscle spasms and tension, while depolarizing muscle relaxants are used to reduce muscle stiffness. The Muscle Relaxant market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. These companies offer a range of products, including non-depolarizing and depolarizing muscle relaxants, as well as combination products. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.